MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

486936

Report Date :

22.01.2018

 

IDENTIFICATION DETAILS

 

Name :

R.L. FINE CHEM PRIVATE LIMITED

 

 

Registered Office :

“RLFC House" Plot No C-10, 1st Cross, KSSIDC Industrial Area, Yelahanka, New Town, Bangalore – 560064, Karnataka

Tel. No.:

91-80-42488999

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

02.08.2011

 

 

Com. Reg. No.:

08-059846

 

 

Capital Investment / Paid-up Capital :

INR 0.627 Million

 

 

CIN No.:

[Company Identification No.]

U24100KA2011PTC059846

 

 

IEC No.:

Not Divulged

 

 

GSTIN No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Divulged

 

 

PAN No.:

[Permanent Account No.]

AAFCR4326L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company is engaged manufacturing of Active Pharmaceutical Ingredients (API), Bulk Drugs and Fine Chemicals. [Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 773000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company incorporated in the year 2011 having satisfactory track.

 

For the financial year ended 2017, the company has witnessed a significant growth in its revenue by 946.47% (approximately). However, reported loss from its operational activities.

 

The rating takes into consideration company’s improving scale of business operation along with healthy networth base and favorable gap between trade payables to its trade receivables.

 

The rating strength is partially offset by excess of borrowings recorded by the company.

 

Trade relations are reported as fair. Business is active. Payments terms are reported to be slow but correct.

 

In view of aforesaid, the company can b considered for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 22.01.2018

 


 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED BY

 

Name :

Mr. Rohit

Designation :

Finance Department

Contact No.:

91-80-42488999

Date :

19.01.2018

 

 

LOCATIONS

 

Registered Office :

“RLFC House" Plot No C-10, 1st Cross, KSSIDC Industrial Area, Yelahanka, New Town, Bangalore – 560064, Karnataka, India

Tel. No.:

91-80-42488999

Fax No.:

91-80-28566630

E-Mail :

gvreddy@rlfinechem.com

info@rlfinechem.com 

vp.finance@rlfinechem.com

Website :

www.rlfinechem.com

Location :

Owned 

Locality :

Industrial

 

 

Corporate Office:

“RLFC House" Plot No C-10, 1st Cross, KSSIDC Industrial Area, Yelahanka, New Town, Bangalore – 560064, Karnataka, India 

 

 

Factory:

Plot No. JP -27-29, Industrial Area, 1st Phase, Gauribidanur, Chikkaballapur – 561208, Karnataka, India 

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Sadananda Thimma Poojary

Designation :

Director

Address :

No 64, 1st A Main, 3rd Cross, BTM Layout, Bangalore – 576076, Karnataka, India 

Date of Appointment :

26.08.2016

DIN No.:

03642316

 

 

Name :

Mr. Lalit Rai

Designation :

Director

Address :

Row House No. 06, Hermes Heritage, Phase I, Shastri Nagar, Yerwada, Pune -411006, Maharashtra, India

Date of Appointment :

26.08.2016

DIN No.:

07480522

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

No. of Shares

%

Trishna Roy

10000

16.00

Tanushree Roy

10000

16.00

Sumitra Roy

6000

10.00

Anjan K Roy

6000

10.00

Mape Pharma Science LLP, India

11419

18.00

Chandrapore Estates Private Limited

19326

30.00

Total

62745

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged manufacturing of Active Pharmaceutical Ingredients (API), Bulk Drugs and Fine Chemicals. [Registered Activity]

 

 

Products / Services :

ITC Code

Product/ Services Description

99884290

Chemical Bulk Drugs

 

 

Brand Names :

Not Divulged 

 

 

Agencies Held :

Not Divulged 

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Bank Name

RBL Bank Limited

Branch

Shahupuri, Kolhapur -416001, Maharashtra, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

SECURED LOANS

31.03.2017

INR In Million

31.03.2016

INR In Million

LONG TERM BORROWINGS

 

 

Term Loans

 

 

From financial institutions*

1048.470

0.000

SHORT TERM BORROWINGS

 

 

Loan from Bank *

 

 

Cash Credit Loan **

39.406

0.000

Packing credit foreign currency loan **

183.248

0.000

Buyers Credit ***

23.064

0.000

Total

1294.188

0.000

 

Note:

 

LONG TERM BORROWINGS

 

* Terms:

 

The principal amount of facility is repayable in 20 quarterly installments starting from December 2016. The interest rate on this is loan is presently 13.50% per annum payable monthly. 

 

Security:

 

The rupee terms loan with Nomura Capital (India) Private Limited and Tata Capital Financial Services Limited are secured by first ranking mortgage/charge/security interest:

 

a) Pledge of shares and compulsory convertible debentures (CCD’s) held by “Mape PharmaScience LLP” and “Chandrapore Estate Private Limited”.

 

b) Equitable mortgage all immovable fixed assets of the borrower including land parcel at Hindupur, Gowribidanur and Dabaspet.

 

c) All moveable fixed assets including the assets acquired under the slump sale including patents, license, trademark, DMFs, etc. and rights over all contract and account of borrower.

 

d) Second charge on current assets to the extent such current assets are charge for the permitted working capital debt othe wise first charge on such current assets of the borrower.

 

SHORT TERM BORROWINGS

 

*The company has availed working capital borrowing from RBL Bank Limited for the purpose letter of credit, bank guarantee, export pre/post shipment, invoice financing cash credit, and LOU for buyer’s credit facility to company. It is repayable on demand and secured by exclusive first immovable fixed assets (present and future) of the Company.

 

**The company is paying interest at the rate of 1 year Marginal cost lending rate (MCLR) + 1.65% p.a. Currently 1 year MCLR is 9.85% (9.85% + 1.65% = 11.50%).

 

***The company is paying commission of 1% of per annum.

 

Auditors :

 

Name :

B S R and Associates LLP

Chartered Accountants

Address :

Maruthi Info-Tech Centre, 11-12/1 Inner Ring Road Kormangala, Bangalore – 560071, Karnataka, India

Tel. No.:

91-80-71347000

Fax No.:

91-80-71347999

PAN No.:

AADFB6889R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises where key managerial personel are interested :

  • Ray Chemicals Private Limited
  • R.I. Fine Chem (Sole Proprietorship)
  • Troy Life Sciences (Sole Proprietorship)
  • Mape Advisory Group Private Limited
  • Mape Securities Private Limited

 

 

Other Related Parties:

  • Chandrapore Estate Private Limited
  • Mape PharmaScience LLP

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2000000

Equity Shares

INR 10/- each

INR 20.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

62745

Equity Shares

INR 10/- each

INR 0.627 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.627

0.320

0.320

(b) Reserves & Surplus

269.785

3.755

(12.409)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

270.412

4.075

(12.089)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1820.332

504.224

0.000

(b) Deferred tax liabilities (Net)

0.000

0.779

0.000

(c) Other long term liabilities

0.000

0.000

220.119

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

1820.332

505.003

220.119

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

245.718

0.000

0.000

(b) Trade payables

283.027

25.445

19.808

(c) Other current liabilities

409.155

27.603

4.543

(d) Short-term provisions

7.737

1.378

0.000

Total Current Liabilities (4)

945.637

54.426

24.351

 

 

 

 

TOTAL

3036.381

563.504

232.381

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

580.304

76.341

75.570

(ii) Intangible Assets

961.474

16.000

20.000

(iii) Capital work-in-progress

372.849

351.176

93.547

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

154.074

21.106

0.000

(e) Other Non-current assets

0.071

0.000

0.000

Total Non-Current Assets

2068.772

464.623

189.117

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

357.020

10.650

0.000

(c) Trade receivables

424.987

58.340

2.884

(d) Cash and cash equivalents

11.829

0.116

2.689

(e) Short-term loans and advances

124.281

29.575

37.691

(f) Other current assets

49.492

0.200

0.000

Total Current Assets

967.609

98.881

43.264

 

 

 

 

TOTAL

3036.381

563.504

232.381

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

919.789

87.894

5.874

 

Other Income

39.263

0.082

0.000

 

TOTAL

959.052

87.976

5.874

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

564.390

0.000

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(222.598)

0.000

0.000

 

Employees benefits expense

127.731

28.546

12.758

 

Other expenses

242.003

32.211

4.489

 

TOTAL

711.526

60.757

17.247

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

247.526

27.219

(11.373)

 

 

 

 

 

Less

FINANCIAL EXPENSES

168.841

0.000

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

78.685

27.219

(11.373)

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

101.157

4.451

0.068

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(22.472)

22.768

(11.441)

 

 

 

 

 

Less

TAX

(0.575)

6.604

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

(21.897)

16.164

(11.441)

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

(434.06)

505.12

(357.51)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

242.270

0.000

NA

Cash flow from (used in) operations

(178.864)

(23.738)

NA

Net cash used in operating activities

(181.828)

(28.185)

NA

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

[Sundry Debtors / Income * 365]

168.65

242.27

179.21

 

 

 

 

Account Receivables Turnover

[Income / Sunday Debtors]

2.16

1.51

2.04

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

183.04

NA

NA

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.69

2.56

NA

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.13

0.06

(0.06)

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.99

0.99

0.10

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

8.54

123.74

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

3.50

13.36

(2.01)

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

7.08

108.84

(15.64)

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

1.47

0.00

0.00

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

PAT to Sales

((PAT / Sales) * 100)

%

(2.38)

18.39

(194.77)

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(0.72)

2.87

(4.92)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

(8.10)

396.66

94.64

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.02

1.82

1.78

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.65

1.62

1.78

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.09

0.01

-0.05

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

3681.53

1575.70

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.02

1.82

1.78

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

0.320

0.320

0.627

Reserves & Surplus

(12.409)

3.755

269.785

Net worth

(12.089)

4.075

270.412

 

 

 

 

Long Term borrowings

0.000

504.224

1820.332

Short Term borrowings

0.000

0.000

245.718

Total borrowings

0.000

504.224

2308.320

Debt/Equity ratio

0.000

123.736

8.536

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

5.874

87.894

919.789

 

 

1396.323

946.475

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

5.874

87.894

919.789

Profit/ (Loss)

(11.441)

16.164

(21.897)

 

(194.77%)

18.39%

(2.38%)

 


LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

BACKGROUND:

 

Subject was incorporated on 02 august 2011. The objective of the Company is manufacture Active Pharmaceutical Ingredients (API) in India the head office of the Company is in Bangalore.

 

On 24th August 2016, the Company acquired the basis of RL Fine Chem (‘the Sole Proprietorship’ or ‘RFC’) and Ray Chemicals Private Limited (‘RCPL’) on a slump sale basis RFC and RCPL were in the business of manufacturing Bulk Drug and Fine Chemicals for the purpose of commercial and industrial use. The Company has API manufacturing plants and Research and Development Centre situated at Bangalore. The Company is engaged in manufacturing of API specializing central nervous system as well as cardiovascular system molecules. The Company is and United States Food and Drug Administration approved, Japanese Pharmaceuticals and Medical Devices Agency Certified, WHO-GMP, Having COS, ISO 9001 Certified, Manufacturing Products as per ICH Q7 Guideline and their R&D is approved by DSIR New Delhi, India.

 

During the year ended 31st March, 2017, the Company had issued 16314 compulsorily convertible debentures with a face value of INR 9375 each to Mape PharmaScience LLP and 27608 compulsorily convertible debentures with a face value of INR 9375 each to Chandrapore Estate Private Limited.

 

 

UNSECURED LOANS:

 

Particulars

31.03.2017

INR In Million

31.03.2016

INR In Million

LONG-TERM BORROWINGS

 

 

Debentures

 

 

43922 0.1% Compulsorily Convertible Debentures of INR 0.009 each

411.769

0.000

Loan from Related Parties

 

 

Anjan K Roy **

113.179

504.224

Chandrapore Estate Private Limited#

144.994

0.000

Mape Securities Private Limited#

32.420

0.000

Jacob Mathew #

20.000

0.000

Ray Chemicals Private Limited#

49.500

0.000

Total

771.862

504.224

Note:

 

**The Company is paying interest on unsecured loan from Mr. Anjan K Roy w.e.f. 25 August 2016 at a rate of 13% p.a. the loan is repayable based on mutually agreed terms. The company intends to repay this beyond 12 months from the balance sheet date.

 

# the Company had obtained unsecured interest free loan from related parties. These loans are repayable based on mutually agreed terms. The company intends to repay these beyond 12 months from the balance sheet date. 

 

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

AMOUNT

ADDRESS

1

G33925900

100056649

RBL BANK LIMITED

29/09/2016

11/01/2017

300000000.0

SHAHUPURI, KOLHAPUR-416001, MAHARASHTRA, INDIA

2

G48148779

100050892

IDBI TRUSTEESHIP SERVICES LIMITED

23/08/2016

15/06/2017

1400000000.0

ASIAN BUILDING, GROUND FLOOR, 17, R. KAMANI MARG, BALLARD ESTATE, MUMBAI – 400001, MAHARASHTRA, INDIA

 

FIXED ASSETS:

 

  • Land
  • Building
  • Plant and Machinery
  • Furniture and Fittings
  • Office Equipment

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.72

UK Pound

1

INR 88.64

Euro

1

INR 78.14

 

 

 

Information Gathered by :

SHL

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

GEET


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.